Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus

European Journal of Pharmacology

Volumn 330, Issue 2-3, 1997, Pages 129-137

  Dupouy, Véronique ^a   Zajac, Jean Marie ^a  

^a CNRS   (France)

Author keywords

Dorsal raphe nucleus; Morphine analgesia; Neuropeptide FF; Parafascicular nucleus; Rat; Receptors; Serotonin

Indexed keywords

FENCLONINE; MORPHINE; NEUROPEPTIDE; NEUROPEPTIDE FF; NEUROPEPTIDE FF DERIVATIVE; NEUROPEPTIDE RECEPTOR; OXIDOPAMINE; SEROTONIN; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEROTONINERGIC NERVE CELL; THALAMUS PARAFASCICULAR NUCLEUS;

5,6-DIHYDROXYTRYPTAMINE; ANALGESICS, OPIOID; ANIMALS; DRUG INTERACTIONS; FENCLONINE; MALE; MICROINJECTIONS; MORPHINE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; SEROTONIN; SEROTONIN AGENTS; THALAMIC NUCLEI;

EID: 0030787404     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01017-0     Document Type: Article

References (56)

1. Allard M., Geoffre S., Legendre P., Vincent J.D., Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: A binding study. Brain Res. 500:1989;169-176.
2. Allard M., Theodosis D.T., Rousselot P., Lombard M.C., Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: Biochemical and immunocytochemical studies. Neuroscience. 40:1991;81-92.
3. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience. 49:1992;101-116.
4. Allard, M., Rivot, J.P., Stinus, L., Delort-Laval, S., Bertrand, A., Weil-Fugazza, J., 1996. In: Abstracts 8th World Congress on Pain.
5. Allen D.L., Johnson A.E., Tempel A., Zukin R.S., Luine V.N., McEwen B.S. Serotoninergic lesions decrease μ- and δ-opiate receptor binding in discrete areas of the hypothalamus and in the midbrain central gray. Brain Res. 625:1993;269-275.
6. Andersen E., Dafny N. An ascending serotoninergic pain modulation pathway from dorsal raphe nucleus to the parafascicularis nucleus of the thalamus. Brain Res. 269:1983;57-67.
7. Bandler R., Shipley M.T. Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression? Trends Neurosci. 17:1994;379-389.
8. Besson J.-M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67:1987;67-186.
9. Chen J., Zeng S.-L., Rao Z.-R., Shi J.-W. Serotoninergic projections from the midbrain periaqueductal gray and nucleus raphe dorsalis to the nucleus parafascicularis of the thalamus. Brain Res. 584:1992;294-298.
10. Clements J.R., Beitz A.J., Fletcher T.F., Mullett M.A. Immunocytochemical localization of serotonin in the rat periaqueductal gray: A quantitative light and electron microscopic study. J. Comp. Neurol. 236:1985;60-70.
11. Deakin J.F.W., Dostrovsky J.O. Involvement of the periaqueductal grey matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia: Effects of lesions and 5-hydroxytryptamine depletion. Br. J. Pharmacol. 63:1978;159-165.
12. Descarries L., Watkins K.C., Garcia S., Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: A light and electron microscope radioautographic study. J. Comp. Neurol. 207:1982;239-254.
13. Desprat C., Zajac J.-M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev. Brain Res. 82:1994;118-126.
14. Devillers J.-P., Mazarguil H., Allard M., Dickenson A.H., Zajac J.-M., Simonnet G. Characterization of a potent agonist for NPFF receptors: Binding study in rat spinal cord membranes. Neuropharmacology. 33:1994;661-669.
15. Dong W.-Q., Qiao J.-T., Skolnick M., Dafny M. Focal dorsal raphe stimulation and pinnal electrical stimulation modulate spontaneous and noxious evoked responses in thalamic neurons. Int. J. Neurosci. 57:1991;123-140.
16. Dupouy, V., 1995. Neuroanatomie Fonctionnelle du Neuropeptide FF, Relation avec les Systèmes Opioïdes. Université Paul Sabatier, Toulouse III.
17. Dupouy V., Zajac J.-M. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul. Pept. 59:1995;349-356.
18. 3] NPFF Synapse. 24:1996;282-296.
19. Dupouy V., Puget A., Eschalier A., Zajac J.-M. Species differences in the localization of neuropeptide FF receptors in rodents and lagomorph brain and spinal cord. Peptides. 17:1996;399-405.
20. Fardin V., Oliveras J.-L., Besson J.-M. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. I. The production of behavioral side effects together with analgesia. Brain Res. 306:1984;105-123.
21. Field H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14:1991;219-245.
22. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.-M. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222:1992;61-67.
23. Gicquel S., Fioramonti J., Bueno L., Zajac J.-M. Effects of F8Famide analogs on intestinal transit in mice. Peptides. 14:1993;749-753.
24. Gicquel S., Mazarguil H., Desprat C., Allard M., Devillers J.-P., Simonnet G., Zajac J.-M. Structure-activity study of Neuropeptide FF: Contribution of N-terminal regions to affinity and activity. J. Med. Chem. 37:1994;3477-3481.
25. Gouardères C., Sutak M., Zajac J.-M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
26. Gouardères C., Jhamandas K., Sutak M., Zajac J.-M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117:1996;493-501.
27. Kavaliers M., Yang H.-Y.T. IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides. 10:1989;741-745.
28. Kivipelto L., Majane E.A., Yang H.-Y.T., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like peptides in the central nervous system of rats. J. Comp. Neurol. 286:1989;269-287.
29. Kuraishi Y., Harada Y., Aratani S., Satoh M., Takagi H. Separate involvement of the spinal noradrenergic and serotoninergic systems in morphine analgesia: The differences in mechanical and thermal algesic tests. Brain Res. 273:1983;245-252.
30. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H.-Y.T., Malin D.H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci. Lett. 132:1991;29-32.
31. Majane E.A., Casanova M.F., Yang H.-Y.T. Biochemical characterization of FMRFNH2-like peptide in spinal cord of various mammalian species using specific radioimmunoassays. Peptides. 9:1988;1137-1144.
32. Malin D.H., Lake J.R., Fowler D.E., Hammond M.V., Brown S.L., Leyva J.E., Prasco P.E., Dougherty T.M. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides. 11:1990;277-280.
33. Malin D.H., Lake J.R., Hammond M.V., Fowler D.E., Rogillio R.B., Brown S.L., Sims J.L., Leecraft B.M., Yang H.-Y.T. FMRF-NH2-like mammalian octapeptide: Possible role in opiate dependence and abstinence. Peptides. 11:1990;969-972.
34. McCluny R.E., Dafny N. The parafascicular nucleus of the thalamus exhibits convergence input from the dorsal raphe and the spinal tract of the trigeminal nerve. Brain Res. 197:1980;525-531.
35. Millon M., Fioramonti J., Gicquel S., Zajac J.-M., Bueno L. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats. J. Pharm. Exp. Ther. 265:1993;96-102.
36. Moore R.Y., Halaris A.E., Jones B.E. Serotonin neurons of the midbrain raphe: Ascending projections. J. Comp. Neurol. 180:1978;417-438.
37. Morgan M.M., Sohn J.-H., Liebeskind C. Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level. Brain Res. 502:1989;61-66.
38. Nishikawa T., Scatton B. Evidence for a GABAergic inhibitory influence on serotonergic neurons originating from the dorsal raphe. Brain Res. 279:1983;325-329.
39. Oberling P., Stinus L., Le Moal M., Simonnet G. Biphasic effect on nociception and antiopiate activity of Neuropeptide FF (FLFQPQRFamide) in the rat. Peptides. 14:1993;919-924.
40. Panula P., Kivipelto L., Nieminen O., Majane E.A., Yang H.-Y.T. Neuroanatomy of morphine-modulating peptides. Med. Biol. 65:1987;127-135.
41. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press Australia, Sydney.
42. Peshanski M., Guilbaud G.G., Gautron M. Posterior intralaminar nuclei in the rat neuronal responses to noxious and non-noxious cutaneous stimuli. Exp. Neurol. 72:1981;226-238.
43. Qiao J.T., Dafny N. Dorsal raphe stimulation modulates nociceptive responses in thalamic parafascicular neurons via an ascending pathway. Pain. 34:1988;65-74.
44. Rebeyrolles S., Zajac J.-M., Roumy M. Neuropeptide FF reverses μ-opioid effect on Ca2+ channels in rat spinal ganglion neurons. NeuroReport. 7:1996;2979-2981.
45. Reyes-Vazquez C., Qiao J.-T., Dafny N. Nociceptive responses in nucleus parafascicularis thalami are modulated by dorsal raphe stimulation and microiontophoretic application of morphine and serotonin. Brain Res. Bull. 23:1989;405-411.
46. Roumy M., Zajac J.-M. Effects of Neuropeptide FF on intracellular calcium in mouse spinal ganglion neurones. Eur. J. Pharmacol. 306:1996;291-295.
47. Sakata S., Shima F., Kato M., Fukui M. Effects of thalamic parafascicular stimulation on the periaqueductal gray and adjacent reticular formation neurons. A possible contribution to pain control mechanisms. Brain Res. 451:1988;85-96.
48. Sanders K.H., Klein C.E., Mayer T.E., Heym C., Handwerker H.O. Differential effects of noxious and nonnoxious imput on neurones according to location in ventral periaqueductal grey or dorsal raphe nucleus. Brain Res. 186:1980;83-97.
49. Sharpe L.G., Garnett J.E., Cicero T.J. Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat. Behav. Biol. 11:1974;303-313.
50. Stinus L., Allard M., Gold L., Simonnet G. Change in CNS Neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides. 16:1995;1235-1241.
51. Tang J., Yang H.-Y.T., Costa E. Inhibition of spontaneous and opiate-modified nociception by an endogenous neuropeptide with Phe-Met-Arg-Phe-NH2-like immunoreactivity. Proc. Natl. Acad. Sci. 81:1984;5002-5005.
52. Wang Q.-P., Nakai Y. Enkephalinergic innervation of GABAergic neurons in the dorsal raphe nucleus of the rat. Brain Res. Bull. 32:1993;315-320.
53. Wang Q.P., Nakai Y. The dorsal raphe: An important nucleus in pain modulation. Brain Res. Bull. 34:1994;575-585.
54. Wang Q.-P., Ochiai H., Nakai Y. GABAergic innervation of serotonergic neurons in the dorsal raphe nucleus of the rat studied by electron microscopy double immunostaining. Brain Res. Bull. 29:1992;943-948.
55. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of the two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. 82:1985;7757-7761.
56. 2) from rat spinal cord. Brain Res. 592:1992;326-332.